Thus, CRT generally overexpressed in tumors can be exploited as a target for developing adjuvants (like DAMC) to radiotherapy that directly enhances radiation‐induced death of tumor cells, besides triggering immunogenic death linked to its membrane localization following irradiation.11 The gene discussed is CALR; the disease is neoplasm.